This story has been updated to include information about an additional competing single-cell sequencing technology.

NEW YORK (GenomeWeb) – True to a timeline announced last year, Illumina and Bio-Rad have launched a single-cell sequencing system for research use. The system was codeveloped by the firms, which will also jointly market and sell the product.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.